提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
ナビゲーションに移動
検索に移動
Correlates of Protection
Definitions of terms
Correlates of Protection (CoP)
|
An immune response statistically correlated with protection
|
Mechanistic CoP (mCoP)
|
An immune response responsible for protection
|
Non-mechanistic CoP (nCoP)
|
An immune response surrogating mCoP and easily measured
|
Identifying method of CoP (mCoP)
- Theoretically
- To measure immune responses at the time of exposure to the infection and compare them between those who get infection and not
- might be feasible by detecting immune responses of bloods donated just before an outbreak
- Practically
- To measure immune responses after the vaccination and compare them between those who get infection and not
- usually done in vaccine clinical trial phase 3
- To measure immune responses at the time of challenging exposure of vaccinated volunteers
- would be ethically approved only for milder and/or treatable infections such as seasonal influenza, cholera, dengue or cytomegalovirus
- To extrapolate vaccinated animal challenge model
- To extrapolate protective level of dosing of passive immunization (antibody treatment)
Be careful
- "Immune reseponses" contain various kinds of immunological functions
- Serum antibodies with multiple isotypes and multiple functions
- Mucosal antibodies with multiple isotypes and multiple functions
- Helper T cells
- Killer T cells
- Regulatory T cells
- etc.
- Protection against infection is generally different from protection against disease
- You should focus on which type of protection you expect
|
Protection against infection |
Protection against disease
|
Polio
|
Infection is prevented by mucosal antibodies at nasopharynx and intestine (IgA + diffused IgG)
|
Disease (paralysis) is prevented by serum antibodies before entering CNS via blood
|
Pneumococcus
|
Infection (bacteremia) is prevented by 0.20-0.35 µg/mL (ELISA) of serum antibodies
|
Disease (pneumonia, otitis media, nasopharynx carriage) is prevented by >10 times higher serum antibodies
|
An example of measles
|
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990). Measles Antibody: Reevaluation of Protective Titers. In The Journal of Infectious Diseases (Vol. 162). https://doi.org/10.1093/infdis/162.5.1036
|